A decade of pharma discovery delivers new tools targeting trace amine-associated receptor 1

Neuropsychopharmacology

Volumn 37, Issue 12, 2012, Pages 2553-2554

  Tallman, Katie R ^a   Grandy, David K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 IODOTHYRONAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; BETA 2 ADRENERGIC RECEPTOR; CENTRAL STIMULANT AGENT; DOPAMINE; G PROTEIN COUPLED RECEPTOR; METHAMPHETAMINE; MONOAMINE; NEUROTRANSMITTER; PHENETHYLAMINE; RO 5073012; RO 5203648; SEROTONIN; TRACE AMINE ASSOCIATED RECEPTOR 1; UNCLASSIFIED DRUG;

BEHAVIOR; BEHAVIOR DISORDER; BRAIN; CLINICAL PHARMACOLOGY; COGNITION; CROSS COUPLING REACTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LOCOMOTION; MENTAL DISEASE; MONOAMINERGIC SYSTEM; MOOD; NERVE CELL; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; NOTE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE;

AMPHETAMINE; ANIMALS; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM STIMULANTS; RECEPTORS, G-PROTEIN-COUPLED; SYNAPTIC TRANSMISSION;

EID: 84867499697     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.148     Document Type: Note

References (9)

1. Barger G, Walpole GS (1909). Isolation of the pressor principles of putrid meat. J Physiol 38: 343-352.
2. Grandy DK (2007). Trace amine-associated receptor 1Ffamily achetype or iconoclast? Pharmacol Ther 116: 355-390.
3. Ledonne A, Berretta N, Davoli A, Rizzo GR, Bernardi G, Mercuri NB (2011). Electrophysiological effects of trace amines on mesencephalic dopaminergic neurons. Front Syst Neyrosci 5: 1-5.
4. Liberles SD, Buck LB (2006). A second class of chemosensory receptors in the olfactory epithelium. Nature 442: 645-650.
5. Revel FG, Meyer CA, Bradaia A, Jeanneau K, Calcagno E, André CB et al (2012a). Brain-specific overexpression of trace amineassociated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine. Neuropsychopharmacology 37: 2580-2592.
6. Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R et al (2011). TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypogluatmatergic activity. Proc Natl Acad Sci USA 108: 8485-8490.
7. Revel FG, Moreau JL, Gainetdinov RR, Ferragud A, Velázquez- Sánchez C, Sotnikova TD et al (2012b). Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol Psychiatry; e-pub ahead of print 15 June 2012 (in press).
8. Wolinsky TD, Swanson CJ, Smith KE, Zhong H, Borowsky B, Seeman P et al (2007). The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav 6: 628-639.
9. Xie Z, Westmoreland S, Bahn ME, Chen GL, Yang H, Vallender EV et al (2007). Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation bt the D2 autoreceptor in vitro. J Pharmacol Exp Ther 321: 116-127.